The Latest Cardiac and Vascular News
AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of FARXIGA (dapagliflozin) to delay the progression of renal failure and prevent cardiovascular (CV) and renal death in patients with chronic kidney disease (CKD). The FDA’s Fast Track program is designed […]
MedAxiom New Survey of 2,300 physicians reveals impactful health care industry trends NEPTUNE BEACH, Fla.–(BUSINESS WIRE)–MedAxiom, an American College of Cardiology Company, the nation’s leading cardiovascular health care performance community and top cardiovascular-specific consulting firm, has released its seventh annual. The report reveals trends that help cardiovascular organizations navigate an […]
Dr. Donohoe brings nearly 30 years of successful clinical and regulatory experience advancing medical devices in the cardiology and endovascular space NEW HOPE, Pa., Aug. 27, 2019 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs in […]
REDWOOD CITY, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD) today announced the closing of an underwritten public offering of 3,813,559 shares of its common stock at a price of $1.18 per share, for total gross proceeds […]
BOSTON, Aug. 27, 2019 (GLOBE NEWSWIRE) — LifePod® Solutions Inc., the groundbreaking, proactive-voice caregiving service, has joined the American Heart Association’s Center for Health Technology & Innovation (the Center) Innovators Network to implement a first-of-its-kind heart failure study to support CarePlan adherence among those suffering from chronic heart conditions. The Center is focused […]
Multiple Papers and Presentations Highlight REDUCE-IT and Vascepa® Potential Mechanisms of Action of Vascepa Becoming Better Understood American Heart Association References REDUCE-IT in Scientific Advisory BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 27, 2019 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, today provided […]
BE’ER SHEVA, Israel, and SHENZEN, China, Aug. 27, 2019 /PRNewswire/ — DiA Imaging Analysis Ltd. (DiA), a leading provider of artificial intelligence (AI)-powered ultrasound analysis solutions, announced a partnership with Edan Instruments Inc., a leading medical products and services company. Ultrasound is a $7B market rapidly growing, adding new users in various point-of-care settings. Yet, acquiring the […]
Expands Solutions for Cardiac Arrest Victims in the Community CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today confirmed that it has completed the previously announced acquisition of Cardiac Science® Corporation, a leading provider of automated external defibrillators (AEDs), related […]
SUNNYVALE, Calif., Aug. 27, 2019 /PRNewswire/ — EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced it has closed $30M in new funding to complete enrollment of its pivotal SOLVE CRT clinical trial and to prepare for commercialization of the WiSE Cardiac Resynchronization Therapy (CRT) System. This […]
Clinical evidence demonstrates that AtriClip® devices exclude and electrically isolate the left atrial appendage MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatment for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of […]
